Cite

    Misumida, N. et al. (2018). Efficacy and safety of short‐term dual antiplatelet therapy (≤6 months) after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta‐analysis of randomized controlled trials. Clinical cardiology. 41 (11), pp. 1455-1462. [Online].